BRKR Financials Bruker Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 30 h ago Overview →

Growth & profitability

Revenue has grown 11.6% per year over the past 5 years.
Operating margin has contracted, at 2.0% in the latest year.
Free cash flow has declined 28.7% per year over the past 5 years.

Financial health

Total debt ($1.9B) exceeds cash ($299M); net debt is $1.6B.
Total debt has grown faster than revenue (17.2% vs 11.6% per year).
Operating income covered interest expense 1.1× in the latest year.
Total debt is 6.5× EBITDA.

Shareholder returns

Dividends have been paid for 10 consecutive years, consuming 52.7% of free cash flow.
The dividend has declined 1.5% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
2025	$3.4B	-$8M	45.9%	2.0%	$43M	$1.9B	$299M
2024	$3.4B	$114M	49.0%	7.5%	$136M	$2.1B	$183M
2023	$3.0B	$429M	51.0%	14.7%	$243M	$1.3B	$488M
2022	$2.5B	$299M	51.6%	17.1%	$145M	$1.2B	$646M
2021	$2.4B	$281M	50.0%	17.1%	$190M	$1.3B	$1.1B
2020	$2.0B	$158M	47.3%	12.5%	$235M	$845M	$682M
2019	$2.1B	$197M	48.0%	14.5%	$140M	$813M	$678M
2018	$1.9B	$180M	47.5%	13.8%	$191M	$341M	$322M
2017	$1.8B	$79M	46.2%	12.4%	$111M	—	$325M
2016	—	$154M	—	—	$94M	—	$342M
2015	—	$102M	—	—	$195M	—	$267M
2014	—	$57M	—	—	—	$355M	$320M
2013	—	$80M	—	—	—	$355M	$439M
2012	—	$78M	—	—	—	$337M	$311M
2011	—	$92M	—	—	—	$303M	$246M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
Mar '26	$823M	$14M	46.1%	1.2%	$47M	$1.7B	$133M
Dec '25	$977M	$26M	46.0%	7.8%	$207M	$1.9B	$299M
Sep '25	$861M	-$60M	44.1%	-6.0%	-$54M	$2.0B	$293M
Jun '25	$797M	$8M	44.9%	1.5%	-$149M	$2.4B	$92M
Mar '25	$801M	$17M	48.8%	4.0%	$39M	$2.1B	$184M
Dec '24	$980M	$14M	50.4%	7.4%	$153M	$2.1B	$183M
Sep '24	$864M	$41M	48.4%	7.9%	$6M	$2.3B	$148M
Jun '24	$801M	$8M	48.0%	6.0%	-$24M	$2.2B	$170M
Mar '24	$722M	$51M	48.9%	9.0%	$400000	$1.4B	$340M
Dec '23	$855M	$206M	50.4%	12.1%	$174M	$1.3B	$488M
Sep '23	$743M	$88M	51.5%	16.8%	$17M	$1.2B	$364M
Jun '23	$682M	$57M	49.9%	12.6%	-$11M	$1.2B	$575M
Mar '23	$685M	$77M	52.5%	17.9%	$63M	$1.2B	$598M
Dec '22	$708M	$97M	51.7%	18.5%	$137M	$1.2B	$646M
Sep '22	$639M	$88M	52.5%	20.6%	$12M	$1.2B	$626M
Jun '22	$588M	$50M	50.7%	12.6%	-$62M	$1.2B	$723M
Mar '22	$595M	$62M	51.5%	16.2%	$59M	$1.2B	$816M
Dec '21	$684M	$76M	50.0%	18.3%	$110M	$1.3B	$1.1B
Sep '21	$609M	$87M	50.7%	18.6%	$8M	$827M	$573M
Jun '21	$571M	$58M	49.2%	15.0%	-$700000	$829M	$608M

Valuation over time

How the market has priced BRKR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 40.2× (Mar '23) to 64.9× (Nov '25).
The price-to-sales ratio has fallen from 4.7× (Mar '23) to 2.7× (Jun '26).
The dividend yield has fallen from 0.2% (Mar '23) to 0.2% (Jun '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is BRKR growing its revenue and profit?

Over the past 5 years, Bruker Corp's revenue has grown 11.6% per year. These are computed facts, not advice.

How much debt does BRKR have?

As of FY2025, Bruker Corp reported $1.9B of total debt against $299M of cash; operating income covered interest expense 1.1×.

What is BRKR's profit margin?

In FY2025, gross margin was 45.9%, operating margin 2.0%, and net margin -0.2%.

What is BRKR's P/E ratio?

As of Jun '26, Bruker Corp traded at a price-to-earnings ratio of about 64.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.